Intervention

exenatide

ClinicalTrials.gov intervention label

Clinical trials43
Recruiting0
Common conditions14
Lead sponsors shown11

Clinical trials

43 shown
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodNCT02787551 · 2016-07-06
COMPLETED
A Comparison of Exenatide and Insulin GlargineNCT02325960 · 2015-01-01
COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 DiabetesNCT01885208 · 2013-12-02
COMPLETED
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyNCT01676116 · 2012-08-29
COMPLETED
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and DiabetesNCT01281228 · 2011-09-01
COMPLETED
Changes in Bone Turnover With Exposure to a GLP-1 Receptor AgonistNCT01381926 · 2011-02-01
TERMINATED
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 DiabetesNCT01060059 · 2010-04-01
COMPLETED
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 DiabetesNCT00960661 · 2009-09-01
COMPLETED
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureNCT00766857 · 2009-05-01
COMPLETED
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusNCT00765817 · 2008-10-01
COMPLETED
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With MetforminNCT00753896 · 2008-10-01
COMPLETED
Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a ThiazolidinedioneNCT00729326 · 2008-08-01
COMPLETED
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With MetforminNCT00701935 · 2008-08-01
TERMINATED
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.NCT00717457 · 2008-07-01
COMPLETED
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)NCT00577824 · 2008-01-01
COMPLETED
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE TherapyNCT00635492 · 2008-01-01
COMPLETED
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and MetforminNCT00603239 · 2008-01-01
COMPLETED
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver DiseaseNCT00529204 · 2007-10-01
TERMINATED
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 DiabetesNCT00516074 · 2007-09-01
COMPLETED
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00518882 · 2007-08-01
COMPLETED
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 DiabetesNCT00516048 · 2007-08-01
COMPLETED
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese PatientsNCT00500370 · 2007-06-01
COMPLETED
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusNCT00477581 · 2007-05-01
COMPLETED
The Effect of Exenatide on Weight and Hunger in Obese, Healthy WomenNCT00456885 · 2007-04-01
COMPLETED
How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 DiabeticsNCT00667732 · 2007-03-01
COMPLETED
Effect on Weight Loss of Exenatide Versus PlaceboNCT00375492 · 2006-09-01
COMPLETED
Exenatide Versus Glimepiride in Patients With Type 2 DiabetesNCT00359762 · 2006-09-01
COMPLETED
Safety and Efficacy of Exenatide as MonotherapyNCT00381342 · 2006-09-01
COMPLETED
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesNCT00359879 · 2006-09-01
COMPLETED
A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes PatientsNCT00360334 · 2006-06-01
COMPLETED
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)NCT00308139 · 2006-04-01
COMPLETED
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.NCT00313001 · 2006-04-01
COMPLETED
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminNCT00324363 · 2006-01-01
COMPLETED
In-patient Study in Patients With Type 2 Diabetes MellitusNCT00259896 · 2005-10-01
COMPLETED
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesNCT00241423 · 2005-10-01
COMPLETED
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusNCT00135330 · 2005-10-01
COMPLETED
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 DiabetesNCT00097500 · 2004-09-01
COMPLETED
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic AgentsNCT01077323 · 2004-09-01
COMPLETED
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminNCT00099320 · 2004-05-01
COMPLETED
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsNCT00099333 · 2004-02-01
COMPLETED
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes MellitusNCT01876849 · 2003-12-01
COMPLETED
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and MetforminNCT00082407 · 2003-11-01
COMPLETED
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesNCT00111540 · 2002-11-01
COMPLETED

Trial status mix

COMPLETED40
TERMINATED3

Phase mix

PHASE326
PHASE47
PHASE25
NA1
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.